Rolf A. Classon, chairman of the board and independent director of EKR Therapeutics, a privately held specialty pharmaceutical company, has resigned effective immediately and will not stand for re-election, according to a press statement from the company.The resignation comes just five months after Classon joined the specialty pharmaceutical company focused on providing acute-care specialty [...]

Louisville-based Chrysalis Ventures led the round, accompanied by Health Evolution Partners and Foundation’s management team. The company plans to use the funding to further invest in its technology and “expand its geographic footprint.”

The Pittsburgh-based imaging services company will use the $10 million to hire new radiologists and expand its diagnostic imaging and radiology service office. Chrysalis Ventures led the round, accompanied by Health Evolution Partners and another group through its Health Evolution Partners Innovation Network.